-
1
-
-
0344442356
-
The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome: The French D. E. S.I. R. study
-
Balkau B, Vernay M, Mhamdi L, Novak M, et al., (2003) The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome: the French D. E. S.I. R. study. Diabetes Metab 29:526-532.
-
(2003)
Diabetes Metab
, vol.29
, pp. 526-532
-
-
Balkau, B.1
Vernay, M.2
Mhamdi, L.3
Novak, M.4
-
2
-
-
58249135655
-
Course of illness in a sample of 265 patients with first-episode psychosis-five year follow-up of the Danish OPUS trials
-
Bertelsen M, Jeppesen P, Petersen L, Thorup A, et al., (2009) Course of illness in a sample of 265 patients with first-episode psychosis-five year follow-up of the Danish OPUS trials. Schizophr Res 107:173-178.
-
(2009)
Schizophr Res
, vol.107
, pp. 173-178
-
-
Bertelsen, M.1
Jeppesen, P.2
Petersen, L.3
Thorup, A.4
-
3
-
-
33846624634
-
Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: Results of the CLAMORS study
-
Bobes J, Arango C, Aranda P, Carmena R, et al., (2007) Cardiovascular and metabolic risk in outpatients with schizophrenia treated with antipsychotics: results of the CLAMORS study. Schizophr Res 90:162-173.
-
(2007)
Schizophr Res
, vol.90
, pp. 162-173
-
-
Bobes, J.1
Arango, C.2
Aranda, P.3
Carmena, R.4
-
4
-
-
77950307734
-
Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: Findings from the CLAMORS study
-
Bobes J, Arango C, Rejas J, for the CLAMORS Study Collaborative Group (2010) Prevalence of negative symptoms in outpatients with schizophrenia spectrum disorders treated with antipsychotics in routine clinical practice: findings from the CLAMORS study. J Clin Psychiatry 71:280-286.
-
(2010)
J Clin Psychiatry
, vol.71
, pp. 280-286
-
-
Bobes, J.1
Arango, C.2
Rejas, J.3
-
5
-
-
70350738289
-
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents
-
Correll CU, Manu P, Olshanskiy V, Napolitano B, Kane JM, et al., (2009) Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. J Am Med Assoc 302:1765-1773.
-
(2009)
J Am Med Assoc
, vol.302
, pp. 1765-1773
-
-
Correll, C.U.1
Manu, P.2
Olshanskiy, V.3
Napolitano, B.4
Kane, J.M.5
-
6
-
-
84856466929
-
Metabolic and cardiovascular adverse effects associated with antipsychotic drugs
-
De Hert M, Detraux J, van Winkel R, Yu W, et al., (2012) Metabolic and cardiovascular adverse effects associated with antipsychotic drugs. Nat Rev Endocrinol 8:114-126.
-
(2012)
Nat Rev Endocrinol
, vol.8
, pp. 114-126
-
-
De Hert, M.1
Detraux, J.2
Van Winkel, R.3
Yu, W.4
-
7
-
-
33646679115
-
Metabolic abnormalities associated with second generation antipsychotics: Facts or fiction? Development of guidelines for screening and monitoring
-
De Hert M, van Eyck D, De Nayer A (2006) Metabolic abnormalities associated with second generation antipsychotics: facts or fiction? Development of guidelines for screening and monitoring. Int Clin Psychopharmacol 21(Suppl. 2):S11-S15.
-
(2006)
Int Clin Psychopharmacol
, vol.21
, Issue.SUPPL. 2
-
-
De Hert, M.1
Van Eyck, D.2
De Nayer, A.3
-
8
-
-
43049144928
-
Typical and atypical antipsychotics differentially affect longterm incidence rates of the metabolic syndrome in firstepisode patients with schizophrenia: A retrospective chart review
-
De Hert MD, Schreurs V, Sweers K, Van Eyck D, et al., (2008) Typical and atypical antipsychotics differentially affect longterm incidence rates of the metabolic syndrome in firstepisode patients with schizophrenia: a retrospective chart review. Schizophr Res 100:295-303.
-
(2008)
Schizophr Res
, vol.100
, pp. 295-303
-
-
De Hert, M.D.1
Schreurs, V.2
Sweers, K.3
Van Eyck, D.4
-
9
-
-
56749102985
-
Identifying metabolic syndrome without blood tests in young adults-the Terneuzen birth cohort
-
de Kroon MLA, Renders CM, Kupiers ECC, van Wouwe JP, et al., (2008) Identifying metabolic syndrome without blood tests in young adults-the Terneuzen birth cohort. Eur J Public Health 18:656-660.
-
(2008)
Eur J Public Health
, vol.18
, pp. 656-660
-
-
De Kroon, M.L.A.1
Renders, C.M.2
Kupiers, E.C.C.3
Van Wouwe, J.P.4
-
10
-
-
33845886915
-
Abdominal obesity and metabolic syndrome
-
Despres JP, Lemieus I (2006) Abdominal obesity and metabolic syndrome. Nature 444:881-887.
-
(2006)
Nature
, vol.444
, pp. 881-887
-
-
Despres, J.P.1
Lemieus, I.2
-
12
-
-
84865627930
-
Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity and body mass index
-
Ervin RB (2009) Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity and body mass index. Natl Health Stat Rep 13:1-7.
-
(2009)
Natl Health Stat Rep
, vol.13
, pp. 1-7
-
-
Ervin, R.B.1
-
14
-
-
44849100969
-
Comorbid somatic illnesses in patients with severe mental disorders: Clinical, policy, and research challenges
-
Fleischhacker WW, Cetkovich-Bakmas M, De Hert M, Hennekens CH, et al., (2008) Comorbid somatic illnesses in patients with severe mental disorders: clinical, policy, and research challenges. J Clin Psychiatry 69:514-519.
-
(2008)
J Clin Psychiatry
, vol.69
, pp. 514-519
-
-
Fleischhacker, W.W.1
Cetkovich-Bakmas, M.2
De Hert, M.3
Hennekens, C.H.4
-
15
-
-
24344442805
-
The European first episode schizophrenia trial (EUFEST): Rationale and design of the trial
-
Fleischhacker WW, Keet IP, Kahn RS (2005) The European first episode schizophrenia trial (EUFEST): rationale and design of the trial. Schizophr Res 7:147-156.
-
(2005)
Schizophr Res
, vol.7
, pp. 147-156
-
-
Fleischhacker, W.W.1
Keet, I.P.2
Kahn, R.S.3
-
16
-
-
0037116641
-
Prevalence of metabolic syndrome among US adults: Findings from the third national health and nutrition examination survey
-
Ford ES, Giles WH, Dietz WH (2002) Prevalence of metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. J Am Med Assoc 287:356-359.
-
(2002)
J Am Med Assoc
, vol.287
, pp. 356-359
-
-
Ford, E.S.1
Giles, W.H.2
Dietz, W.H.3
-
18
-
-
79956072601
-
Cardiovascular risk in patients admitted for psychosis compared with findings from a population-based study
-
Johnsen E, Gjestad R, Kroken RA, Mellesdal L et al., (2011) Cardiovascular risk in patients admitted for psychosis compared with findings from a population-based study. Nord J Psychiatry 65:192-202.
-
(2011)
Nord J Psychiatry
, vol.65
, pp. 192-202
-
-
Johnsen, E.1
Gjestad, R.2
Kroken, R.A.3
Mellesdal, L.4
-
19
-
-
64349086821
-
Prevalence of risk factors for metabolic syndromes in adolescents
-
Johnson WD, Kroon JJM, Greenway FL, Bouchard C, et al., (2009) Prevalence of risk factors for metabolic syndromes in adolescents. Arch Pediatr Med 163:371-377.
-
(2009)
Arch Pediatr Med
, vol.163
, pp. 371-377
-
-
Johnson, W.D.1
Kroon, J.J.M.2
Greenway, F.L.3
Bouchard, C.4
-
20
-
-
44649131269
-
Metabolic syndrome-what is the clinical usefulness?
-
Kahn R (2008) Metabolic syndrome-what is the clinical usefulness? Lancet 371:1892-1893.
-
(2008)
Lancet
, vol.371
, pp. 1892-1893
-
-
Kahn, R.1
-
21
-
-
40949142200
-
Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: An open randomized clinical trial
-
Kahn RS, Fleischhacker WW, Boter H, Davidson M, et al. for the EUFEST study group (2008) Effectiveness of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: an open randomized clinical trial. Lancet 371:1085-1097.
-
(2008)
Lancet
, vol.371
, pp. 1085-1097
-
-
Kahn, R.S.1
Fleischhacker, W.W.2
Boter, H.3
Davidson, M.4
-
22
-
-
77955155398
-
Prevalence of coronary heart disease risk factors and screening for high cholesterol levels among young adults United States 1999-2006
-
Kulina EV, Yoon PW, Keenan NL (2010) Prevalence of coronary heart disease risk factors and screening for high cholesterol levels among young adults, United States, 1999-2006. Ann Fam Med 8:327-333.
-
(2010)
Ann Fam Med
, vol.8
, pp. 327-333
-
-
Kulina, E.V.1
Yoon, P.W.2
Keenan, N.L.3
-
23
-
-
0035040066
-
The clinical implications of weight gain in schizophrenia
-
Kurzthaler I, Fleischhacker WW (2001) The clinical implications of weight gain in schizophrenia. J Clin Psychiatry 62(Suppl. 7):32-37.
-
(2001)
J Clin Psychiatry
, vol.62
, Issue.SUPPL. 7
, pp. 32-37
-
-
Kurzthaler, I.1
Fleischhacker, W.W.2
-
24
-
-
25144456112
-
Effectiveness of antipsychotic drugs in patients with chronic schizophrenia
-
Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, et al. for the Clinical Antipsychotic Trials of Intervention Effectiveness Investigators (2005) Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Eng J Med 35:1209-1223.
-
(2005)
N Eng J Med
, vol.35
, pp. 1209-1223
-
-
Lieberman, J.A.1
Stroup, T.S.2
McEvoy, J.P.3
Swartz, M.S.4
-
25
-
-
27744502054
-
Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia trial and comparison with national estimates from NHANES III
-
McEvoy JP, Meyer JM, Goff DC, Nasrallah HA, et al., (2005) Prevalence of the metabolic syndrome in patients with schizophrenia: baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia trial and comparison with national estimates from NHANES III. Schizophr Res 80:19-32.
-
(2005)
Schizophr Res
, vol.80
, pp. 19-32
-
-
McEvoy, J.P.1
Meyer, J.M.2
Goff, D.C.3
Nasrallah, H.A.4
-
26
-
-
0021813187
-
Homeostasis model assessment: Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
-
Matthews DR, Hosker JP, Rudenski AS, et al., (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28:412-419.
-
(1985)
Diabetologia
, vol.28
, pp. 412-419
-
-
Matthews, D.R.1
Hosker, J.P.2
Rudenski, A.S.3
-
27
-
-
41149131177
-
Arterial structure and function in young adults with the metabolic syndrome: The Cardiovascular Risk in Young Finns Study
-
Mattsson N, Ronnemaa T, Juonala M, Viikari JSA, et al., (2008) Arterial structure and function in young adults with the metabolic syndrome: the Cardiovascular Risk in Young Finns Study. Eur Heart J 29:784-791.
-
(2008)
Eur Heart J
, vol.29
, pp. 784-791
-
-
Mattsson, N.1
Ronnemaa, T.2
Juonala, M.3
Viikari, J.S.A.4
-
28
-
-
27744456032
-
The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: Clinical comparison of subgroups with and without the metabolic syndrome
-
Meyer JM, Nesrallah HA, McEvoy Goff DC, et al., (2005) The Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Schizophrenia Trial: clinical comparison of subgroups with and without the metabolic syndrome. Schizophr Res 80:9-18.
-
(2005)
Schizophr Res
, vol.80
, pp. 9-18
-
-
Meyer, J.M.1
Nesrallah, H.A.2
McEvoy Goff, D.C.3
-
29
-
-
84874544333
-
Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-A systematic review and meta-analysis
-
Published online: 29 December 2011. doi :10.1093/schbul/sbr148
-
Mitchell AJ, Vancampfort D, Sweers K, van Winkel R, et al., (2011) Prevalence of metabolic syndrome and metabolic abnormalities in schizophrenia and related disorders-A systematic review and meta-analysis. Schizophr Bull. Published online: 29 December 2011. doi :10.1093/schbul/sbr148.
-
(2011)
Schizophr Bull
-
-
Mitchell, A.J.1
Vancampfort, D.2
Sweers, K.3
Van Winkel, R.4
-
30
-
-
84874513990
-
Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients
-
Published online: 27 August 2011. doi:10.1093/schbul/sbs082
-
Mitchell AJ, Vancampfort D, De Herdt A, Yu W, De Hert M (2012a) Is the prevalence of metabolic syndrome and metabolic abnormalities increased in early schizophrenia? A comparative meta-analysis of first episode, untreated and treated patients. Schizophr Bull Published online: 27 August 2011. doi:10.1093/schbul/sbs082.
-
(2012)
Schizophr Bull
-
-
Mitchell, A.J.1
Vancampfort, D.2
De Herdt, A.3
Yu, W.4
De Hert, M.5
-
31
-
-
82555172404
-
Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: Systematic review and meta-analysis of screening practices
-
Mitchell AJ, Delaffon V, Vancampfort D, Correll CU, et al., (2012b) Guideline concordant monitoring of metabolic risk in people treated with antipsychotic medication: systematic review and meta-analysis of screening practices. Psychol Med 42:125-147.
-
(2012)
Psychol Med
, vol.42
, pp. 125-147
-
-
Mitchell, A.J.1
Delaffon, V.2
Vancampfort, D.3
Correll, C.U.4
-
32
-
-
79951704858
-
Persistent increase of prevalence of metabolic syndrome among us adults: NHANES III to NHANES 1999-2006
-
Mozumdar A, Liguori G (2011) Persistent increase of prevalence of metabolic syndrome among us adults: NHANES III to NHANES 1999-2006. Diabetes Care 34:216-219.
-
(2011)
Diabetes Care
, vol.34
, pp. 216-219
-
-
Mozumdar, A.1
Liguori, G.2
-
33
-
-
84891629662
-
The metabolic effects of antipsychotic medications
-
Newcomer JW, Haupt DW (2006) The metabolic effects of antipsychotic medications. Can J Psychiatry 59:337-345.
-
(2006)
Can J Psychiatry
, vol.59
, pp. 337-345
-
-
Newcomer, J.W.1
Haupt, D.W.2
-
34
-
-
35348960372
-
Severe mental illness and risk of cardiovascular disease
-
Newcomer JW, Hennekens CH (2007) Severe mental illness and risk of cardiovascular disease. J Am Med Assoc 298:1794-1796.
-
(2007)
J Am Med Assoc
, vol.298
, pp. 1794-1796
-
-
Newcomer, J.W.1
Hennekens, C.H.2
-
35
-
-
77954762965
-
Antipsychotics associated with the development of type 2 diabetes in antipsychotic-näive schizophrenia patients
-
Nielsen J, Skadhede S, Correll CU (2010) Antipsychotics associated with the development of type 2 diabetes in antipsychotic-näive schizophrenia patients. Neuropsychopharmacology 35:1997-2004.
-
(2010)
Neuropsychopharmacology
, vol.35
, pp. 1997-2004
-
-
Nielsen, J.1
Skadhede, S.2
Correll, C.U.3
-
36
-
-
67349136738
-
Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study
-
Patel JK, Buckley PF, Woolson S, Hamer RM, et al., (2009) Metabolic profiles of second-generation antipsychotics in early psychosis: findings from the CAFE study. Schizophr Res 111:9-16.
-
(2009)
Schizophr Res
, vol.111
, pp. 9-16
-
-
Patel, J.K.1
Buckley, P.F.2
Woolson, S.3
Hamer, R.M.4
-
37
-
-
70449440638
-
Dropouts and missing data in psychiatric clinical trials
-
Potkin SG, Siu CO (2009) Dropouts and missing data in psychiatric clinical trials. Am J Psychiatry 166:1295.
-
(2009)
Am J Psychiatry
, vol.166
, pp. 1295
-
-
Potkin, S.G.1
Siu, C.O.2
-
38
-
-
19644394512
-
The metabolic syndrome: Requiescat in pace
-
Reaven GM (2005) The metabolic syndrome: requiescat in pace. Clin Chem 51:931-938.
-
(2005)
Clin Chem
, vol.51
, pp. 931-938
-
-
Reaven, G.M.1
-
39
-
-
34948840329
-
A systematic review of mortality in schizophrenia: Is the differential mortality gap worsening over time?
-
Saha S, Chant D, McGrath J (2007) A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? Arch Gen Psychiatry 64:1123-1131.
-
(2007)
Arch Gen Psychiatry
, vol.64
, pp. 1123-1131
-
-
Saha, S.1
Chant, D.2
McGrath, J.3
-
40
-
-
43049125770
-
Metabolic syndrome in first-episode schizophrenia-A randomized, double-blind controlled, short-term prospective study
-
Saddichha S, Manjunatha N, Ameen S, Akhtar S (2008) Metabolic syndrome in first-episode schizophrenia-a randomized, double-blind controlled, short-term prospective study. Schizophr Res 101:266-272.
-
(2008)
Schizophr Res
, vol.101
, pp. 266-272
-
-
Saddichha, S.1
Manjunatha, N.2
Ameen, S.3
Akhtar, S.4
-
41
-
-
0032421570
-
The mini-international neuropsychiatric interview (M. I. N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10
-
Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, et al., (1998) The mini-international neuropsychiatric interview (M. I. N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 59(Suppl. 20):22-33.
-
(1998)
J Clin Psychiatry
, vol.59
, Issue.SUPPL. 20
, pp. 22-33
-
-
Sheehan, D.V.1
Lecrubier, Y.2
Sheehan, K.H.3
Amorim, P.4
-
42
-
-
0034686717
-
Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity
-
Stamler J, Daviglus ML, Garside DB, Dyer AR, et al., (2000) Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity. J Am Med Assoc 284:311-318.
-
(2000)
J Am Med Assoc
, vol.284
, pp. 311-318
-
-
Stamler, J.1
Daviglus, M.L.2
Garside, D.B.3
Dyer, A.R.4
-
43
-
-
34447341958
-
Metabolic side effects of antipsychotic medication
-
Tschoner A, Engl J, Laimer M, Kaser S, et al., (2007) Metabolic side effects of antipsychotic medication. Int J Clin Pract 18:1356-1370.
-
(2007)
Int J Clin Pract
, vol.18
, pp. 1356-1370
-
-
Tschoner, A.1
Engl, J.2
Laimer, M.3
Kaser, S.4
-
44
-
-
0141755326
-
Insulin sensitivity, insulin secretion and abdominal fat: The insulin resistance atherosclerosis study (IRAS) family study
-
Wagenknecht LE, Langefeld CD, Scherzinger AL, Norris JM, et al., (2003) Insulin sensitivity, insulin secretion and abdominal fat: the insulin resistance atherosclerosis study (IRAS) family study. Diabetes 52:2490-2496.
-
(2003)
Diabetes
, vol.52
, pp. 2490-2496
-
-
Wagenknecht, L.E.1
Langefeld, C.D.2
Scherzinger, A.L.3
Norris, J.M.4
-
45
-
-
0032013736
-
The design and analysis of longitudinal studies of development and psychopathology in context: Statistical models and methodological recommendations
-
Willett JB, Singer JD, Martin NC (1998) The design and analysis of longitudinal studies of development and psychopathology in context: statistical models and methodological recommendations. Dev Psychopathol 10:395-426.
-
(1998)
Dev Psychopathol
, vol.10
, pp. 395-426
-
-
Willett, J.B.1
Singer, J.D.2
Martin, N.C.3
|